Literature DB >> 15336732

Surgical treatment of locally recurrent rectal cancer.

R Bakx1, H van Tinteren, J J B van Lanschot, F A N Zoetmulder.   

Abstract

BACKGROUND: The aim of our study was to analyse data of patients treated by salvage surgery for locally recurrent rectal cancer, with emphasis on the question whether salvage surgery is still worthwhile when adjuvant radiotherapy is no longer a treatment option.
METHODS: Forty patients (19 males/21 females) treated by surgery with curative intent for locally recurrent rectal carcinoma were analysed. Local recurrence was defined as cancer recurrence within the lower pelvis. Salvage surgery included abdominoperineal resection, abdominosacral resection, exenteration (posterior or total) and local resection. Clinical and pathological factors were analysed to identify prognostic factors for survival.
RESULTS: The median overall survival was 25 months (95% CI: 13-37 months) and 5-year survival was 28% (95% CI: 12-45%). The absence of symptoms at the time of recurrence, central localisation and the absence of microscopic involvement of surgical margins, but not additional radiotherapy, were found to be significant independent prognostic factors for better survival after salvage surgery.
CONCLUSION: Salvage surgery, alone or in combination with radiotherapy, can achieve radical resection of locally recurrent rectal cancer and can result in long-term survival.

Entities:  

Mesh:

Year:  2004        PMID: 15336732     DOI: 10.1016/j.ejso.2004.05.020

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

1.  Laparoscopic salvage surgery for recurrent and metachronous colorectal cancer: 15 years' experience in a single center.

Authors:  Soo Yeun Park; Gyu-Seog Choi; Soo Han Jun; Jun-Seok Park; Hye Jin Kim
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

2.  Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.

Authors:  Yun-Feng Yao; Zhi Yang; Zhen-Fu Li; Jin Gu
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

3.  Clinical value of F-FDG PET/CT in assessing suspicious relapse after rectal cancer resection.

Authors:  Long Sun; Yong-Song Guan; Wei-Min Pan; Zuo-Ming Luo; Ji-Hong Wei; Long Zhao; Hua Wu
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

4.  Accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer.

Authors:  D-S Sun; J-D Zhang; L Li; Y Dai; J-M Yu; Z-Y Shao
Journal:  Br J Radiol       Date:  2011-03-08       Impact factor: 3.039

5.  Locally recurrent colorectal cancer: results of surgical therapy.

Authors:  M Kruschewski; M Ciurea; S Lipka; S Daum; L Moser; B Meyer; J Gröne; J Budczies; H J Buhr
Journal:  Langenbecks Arch Surg       Date:  2012-06-28       Impact factor: 3.445

6.  Clinical Pattern of Recurrent Disease during the Follow-Up of Rectal Carcinoma.

Authors:  Thijs Wieldraaijer; Pascal Bruin; Laura A M Duineveld; Pieter J Tanis; Anke B Smits; Henk C P M van Weert; Jan Wind
Journal:  Dig Surg       Date:  2017-03-14       Impact factor: 2.588

Review 7.  Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases.

Authors:  Yolanda Y L Yang; James W Fleshman; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

8.  Management of recurrent rectal cancer: a population based study in greater Amsterdam.

Authors:  Roel Bakx; Otto Visser; Judith Josso; Sybren Meijer; J-Frederik-M Slors; J-Jan-B van Lanschot
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

Review 9.  Intentionally curative treatment of locally recurrent rectal cancer: a systematic review.

Authors:  Pieter J Tanis; Annemiek Doeksen; J Jan B van Lanschot
Journal:  Can J Surg       Date:  2013-04       Impact factor: 2.089

10.  Selection criteria for the radical treatment of locally advanced rectal cancer.

Authors:  Mansel Leigh Davies; Dean Harris; Mark Davies; Malcolm Lucas; Peter Drew; John Beynon
Journal:  Int J Surg Oncol       Date:  2011-10-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.